| 摘要 |
Epigallocatechin-3-gallate (EGCG) inhibits angiogenesis and is useful in treatment and prevention of angiogenesis-dependent and -related diseases, including rheumatoid arthritis, psoriasis, ocular angiogenic diseases, diabetic retinopathy, retinopathy of prematurity, macular degeneration, corneal angiogenesis, graft rejection, neovascular glaucoma, retrolental fibroplasia, rubeosis, Osler-Webber Syndrome, myocardial angiogenesis, plaque neovascularisation, telangiectasia, hemophiliac joints, angiofibroma, wound granulation, cat scratch disease (Rochele minalia quintosa) and ulcers (Helicobacter pyloriinfection). EGCG may be provided by means of green tea.
|
